Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
NCT ID:
NCT00295412
Eligibility Criteria:
Inclusion Criteria:
* Patients with as schizophrenia spectrum disorder
* Patients with a comorbid substance use disorder
Exclusion Criteria:
* Patients already on quetiapine or clozapine
* Patients hospitalized or acutely ill
* Total score lower than 65 on the PANSS
* Pregnancy
* Female subjects of childbearing potential without adequate contraception
* Abnormal liver function (hepatic enzymes more than 3 times the upper normal limits)
* Any clinically meaningful unstable renal, hepatic, cardiovascular, respiratory, cerebrovascular disease or other serious, progressive physical disease.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00295412
Study Brief:
Protocol Section:
NCT00295412